Prevention of Healthcare Associated Infections in Bone Marrow Transplant Patients
NCT ID: NCT02463214
Last Updated: 2019-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2015-09-30
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients
NCT00846352
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
NCT03111745
Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients
NCT07324291
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
NCT00002673
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
NCT04629430
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In rare instances, some of the harmful microbes can cause infections. When a microbe causes an infection while we are in healthcare facilities, they are called "Healthcare-associated infections", or "HAIs". Examples that you may have heard of include Clostridium difficile, and MRSA (methicillin-resistant Staphylococcus aureus). Vancouver General Hospital already has some of the lowest HAI rates in the country. We have dedicated hospital workers that do a great job at preventing HAIs, but we are always looking for ways to be even better.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Room
Standard bone marrow transplant recovery, single occupancy, room
No interventions assigned to this group
Engineered Room
Single occupancy bone marrow transplant recovery room, engineered with touchless devices, and surfaces coated with either copper or titanium dioxide.
Engineered Room
Touchless devices:
Hand sanitizers, faucets, paper towel dispensers, call devices, Ultraviolet C Aseptix™ Disinfection devices above bathroom doors
Copper products:
Room and bathroom entrance door hardware, over bed table and bed side table surfaces, chair metal arms, wardrobe handles and knobs, weigh scale, sinks, grab bars, light switch panels, toilet flush handles, faucets and handles, patient bed rails.
Titanium dioxide paint:
Room walls, head walls, light switches, bathroom wall shelves, toilet tank and bowl, head wall unit fixed equipment, television remote and Bed Control remote
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Engineered Room
Touchless devices:
Hand sanitizers, faucets, paper towel dispensers, call devices, Ultraviolet C Aseptix™ Disinfection devices above bathroom doors
Copper products:
Room and bathroom entrance door hardware, over bed table and bed side table surfaces, chair metal arms, wardrobe handles and knobs, weigh scale, sinks, grab bars, light switch panels, toilet flush handles, faucets and handles, patient bed rails.
Titanium dioxide paint:
Room walls, head walls, light switches, bathroom wall shelves, toilet tank and bowl, head wall unit fixed equipment, television remote and Bed Control remote
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* will be admitted to the leukemia and bone marrow transplant service at Vancouver General Hospital
* admission to the ward anticipated to be approximately 28 days
* undergoing allogenic bone marrow transplant for acute myeloid leukemia
* caring for patient enrolled in the study as a primary nurse
Exclusion Criteria
* patients admitted for stays anticipated to be less than 28 days
* allergies to copper, nickel or titanium
19 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vancouver Coastal Health Research Institute
OTHER
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Linda Hoang
Medical Microbiologist, BC Centre for Disease Control
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linda Hoang, MD FRCPC
Role: PRINCIPAL_INVESTIGATOR
The University of British Columbia
Elizabeth Bryce, MD FRCPC
Role: PRINCIPAL_INVESTIGATOR
The University of British Columbia
Patrick Tang, MD PhD FRCPC
Role: PRINCIPAL_INVESTIGATOR
Sidra Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vancouver General Hospital
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H15-00662
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.